Preimplantation genetic testing for aneuploidy (PGT‑A) is one of the most transformative tools in modern fertility care. It helps us identify embryos with the correct number of chromosomes, reduce miscarriage risk, and select embryos with the highest chance of resulting in a healthy pregnancy.
But like any powerful tool, PGT‑A comes with complexity. And one of the biggest sources of confusion is mosaicism.
At Boston IVF, our goal is to bring clarity to the science and compassion to the decision-making. Because what you learn about your embryos can feel overwhelming.
You deserve explanations that empower—not alarm—you.
In the simplest terms, a mosaic embryo contains a mixture of normal (euploid) and abnormal (aneuploid) cells.
A typical embryo is expected to be:
OR
But many embryos fall in between—a reality we only recognized once next‑generation sequencing became sensitive enough to detect it.
Most aneuploidies (chromosome errors) arise during meiosis, when eggs or sperm are formed.
Mosaicism arises later, during mitosis, when the early embryo is rapidly dividing—meaning some daughter cells get the correct number of chromosomes while others don’t.
Mosaicism can occur:
This matters because PGT‑A tests only trophectoderm cells, not the inner cell mass—so the sample may not fully reflect the entire embryo.
PGT‑A is highly accurate when embryos are clearly euploid or aneuploid. But mosaic results are harder to interpret because:
In fact, research now shows over 100 documented healthy live births from mosaic embryos. This is why mosaicism is not a simple “yes/no” result—it is a spectrum.
Yes—many can. Studies show:
Some mosaic embryos appear to “self‑correct,” meaning that as the embryo develops, healthier cell lines out‑compete abnormal ones. Sometimes abnormal cell lines end up confined to the placenta (confined placental mosaicism), not the fetus.
Large studies now provide clearer insight:
Bottom line: Mosaic embryos are not all equal—and not all unsafe.
A segmental aneuploidy means only a piece of a chromosome—not the entire chromosome—is duplicated or missing.
Some key points:
At Boston IVF, segmental mosaics are considered only after extensive genetic counseling, and always with informed consent.
Our priority is always patient safety, ethical practice, and the best possible outcomes.
Boston IVF:
For example:
A 43‑year‑old patient who has undergone multiple IVF cycles and has one mosaic embryo remaining may consider transfer with careful guidance.
Despite these complexities, PGT‑A remains a powerful tool that can:
PGT‑A excels at identifying which embryos have the best chance—mosaic or not.
We help patients understand:
This is a shared decision-making process—never a directive. You are never alone in interpreting these results.
A mosaic result can feel confusing or frightening. But it does not mean:
✘ your embryo cannot implant
✘ your embryo will become a child with genetic abnormalities
✘ your journey is over
Instead, it means:
✔ your embryo exists on a spectrum
✔ more information—and support—matters
✔ many mosaic embryos do result in healthy births
✔ you have options
✔ our team will guide you every step
At Boston IVF, our mission is to ensure you understand the science and feel supported emotionally as you navigate your options.
Let’s talk—clearly, compassionately, and without pressure. Schedule a consultation with a Boston IVF physician or genetic counselor to explore:
Your embryos are precious. Your decisions deserve clarity. Your future deserves hope.
And we are here—always—to guide you through it.